Cure My Disease

Don't miss your cure!

Log in / Sign up

IgA nephropathy, susceptibility to, 1

MONDO:0008072

Also known as: IGAN1, IgA nephropathy, susceptibility to, 1, Igan, berger disease, glomerulonephritis, IgA, nephritis, IgA type

16 clinical trials for this condition and its sub-types.

Follow this condition to get notified about new trials

Broader categories

Inherited disease susceptibility (81) Disease susceptibility (3) IgA nephropathy, susceptibility to (0)

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 1 Completed 2 Terminated 2

New drug aims to slow kidney disease in IgA nephropathy patients

Disease control Ongoing

This phase 3 trial tests ravulizumab, a drug that blocks part of the immune system, against a placebo in 579 adults with IgA nephropathy—a kidney disease that can lead to kidney failure. The goal is to see if ravulizumab reduces protein in the urine and preserves kidney function …

Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC